Q4 FY25Published 30 May 2025Call held 30 May 2025
514183 Q4 FY25 Earnings Call Transcript & Analysis
EBITDA Margin—PAT Margin—
Standalone revenue grew by 20% in FY25, driven by strong domestic sales.
Read full transcript & analysis
Earnings calls
Black Rose Indus concall ledger
Every earnings call for 514183 — management tone, guidance, KPIs and promise tracking, quarter by quarter.
514183 · 2 transcripts · Chemicals · latest Q4 FY25Q3 FY25Published 07 Feb 2025Call held 07 Feb 2025
514183 Q3 FY25 Earnings Call Transcript & Analysis
Revenue from Operations—+48% YoYEBITDA Margin10%
EBITDA Margin 10.0%. Revenue from operations increased by about 48% year-on-year.
Read full transcript & analysis